Clinical and Molecular Characteristics of Chinese Patients With X-Linked Lymphoproliferative Syndrome Type 1

被引:7
|
作者
An, Yun-Fei [1 ,2 ]
Luo, Xiao-Bo [1 ]
Yang, Xi [1 ]
Wang, Jing [1 ]
Li, Li [1 ]
Zhao, Xiao-Dong [1 ,2 ]
机构
[1] Chongqing Med Univ, Childrens Hosp, Key Lab Child Dev & Disorders, Minist Educ, Chongqing 400014, Peoples R China
[2] Chongqing Med Univ, Childrens Hosp, Div Immunol, Chongqing 400014, Peoples R China
基金
中国国家自然科学基金;
关键词
mild clinical phenotype; primary immunodeficiency; residual SAP expression; X-linked lymphoproliferative syndrome; BARR-VIRUS INFECTION; DISEASE GENE; LYMPHOCYTIC VASCULITIS; SH2D1A; SAP; IMMUNODEFICIENCY; DEFICIENCY; FAMILY; MUTATIONS; RESPONSES;
D O I
10.1002/pbc.25126
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundX-linked lymphoproliferative syndrome type 1 (XLP1) is a rare inherited, life-threatening immunodeficiency disorder caused by mutations in SH2D1A gene. It affect approximately two to three males per million. Fewer than 10 cases with definite gene mutations have been reported in Chinese mainland and no rapid diagnosis method has been established. ProcedureWe determined the clinical and molecular characteristics of five patients with XLP1. The SH2D1A gene were amplified by PCR and sequenced, the SAP expression was analyzed by flow cytometry. ResultsTwo patients had novel SH2D1A mutations and three had mutations that have been previously reported. Three patients presented with fulminant infectious mononucleosis or hemophagocytic lymphohistiocytosis and one presented with lymphoma. Null or decreased SAP expression on PBMCs was noted. The remaining patient presented with unique, recurrent, nonfulminant infectious mononucleosis and bimodal intracellular SAP protein expression. ConclusionsThe overall molecular characteristics and clinical phenotypes of Chinese patients with XLP1 matched previous reports. The unique bimodal intracellular SAP protein expression indicated the presence of some residual SAP-positive T cells that are able to respond to persistent Epstein-Barr virus infection and could explain the relatively mild clinical phenotype of this patient. Pediatr Blood Cancer 2014;61:2043-2047. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:2043 / 2047
页数:5
相关论文
共 50 条
  • [1] X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective
    Panchal, Neelam
    Booth, Claire
    Cannons, Jennifer L.
    Schwartzberg, Pamela L.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [2] Clinical and Genetic Features of 5 Chinese Patients with X-linked lymphoproliferative Syndrome
    Sun, J.
    Ying, W.
    Liu, D.
    Hui, X.
    Yu, Y.
    Wang, J.
    Wang, X.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2013, 78 (05) : 463 - 467
  • [3] Hematopoietic cell transplantation for asymptomatic X-linked lymphoproliferative syndrome type 1
    Tamura, Akihiro
    Uemura, Suguru
    Yamamoto, Nobuyuki
    Saito, Atsuro
    Kozaki, Aiko
    Kishimoto, Kenji
    Ishida, Toshiaki
    Hasegawa, Daiichiro
    Hiroki, Haruka
    Okano, Tsubasa
    Imai, Kohsuke
    Morio, Tomohiro
    Kanegane, Hirokazu
    Kosaka, Yoshiyuki
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2018, 14
  • [4] Preimplantation Genetic Testing for a Chinese Family With X-Linked Lymphoproliferative Syndrome Type 1
    Chen, Songchang
    Shi, Weihui
    Qian, Yeqing
    Wang, Liya
    Zhang, Junyu
    Li, Shuyuan
    Chen, Yiyao
    Chang, Chunxin
    Fei, Hongjun
    Zhang, Lanlan
    Huang, Hefeng
    Xu, Chenming
    FRONTIERS IN GENETICS, 2020, 11
  • [5] X-linked lymphoproliferative syndrome: clinical variants.
    Kondratenko, IV
    Bologov, AA
    Gomes, LA
    Reznik, IB
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1998, 43 (04): : 39 - 42
  • [6] X-linked Inhibitor of Apoptosis Protein Deficiency: More than an X-linked Lymphoproliferative Syndrome
    Aguilar, Claire
    Latour, Sylvain
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (04) : 331 - 338
  • [7] Preemptive hematopoietic cell transplantation for asymptomatic patients with X-linked lymphoproliferative syndrome type 1
    Tomomasa, Dan
    Booth, Claire
    Bleesing, Jack J.
    Isoda, Takeshi
    Kobayashi, Chie
    Koike, Kazutoshi
    Taketani, Takeshi
    Sawada, Akihisa
    Tamura, Akihiro
    Marsh, Rebecca A.
    Morio, Tomohiro
    Gennery, Andrew R.
    Kanegane, Hirokazu
    CLINICAL IMMUNOLOGY, 2022, 237
  • [8] Clinical and Molecular Characterization of X-linked Hyper-IgM Syndrome Patients in China
    An, Y.
    Xiao, J.
    Jiang, L.
    Yang, X.
    Yu, J.
    Zhao, X.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2010, 72 (01) : 50 - 56
  • [9] X-linked lymphoproliferative disease: Clinical, diagnostic and molecular perspective
    Gaspar, HB
    Sharifi, R
    Gilmour, KC
    Thrasher, AJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (03) : 585 - 595
  • [10] Clinical Features and Genetic Analysis of 20 Chinese Patients with X-Linked Hyper-IgM Syndrome
    Wang, Lin-Lin
    Zhou, Wei
    Zhao, Wei
    Tian, Zhi-Qing
    Wang, Wei-Fan
    Wang, Xiao-Fang
    Chen, Tong-Xin
    JOURNAL OF IMMUNOLOGY RESEARCH, 2014, 2014